Breslow Thickness and Microsatellite Detection in Primary Cutaneous Melanoma: Implications for Oncologic Surgeons and Patients
The American Surgeon™ · 2026-09 · 92 (9) · 2257-2262
DOI: 10.1177/00031348261448890 ↗Kurz gefasst
Fachartikel in der Zeitschrift The American Surgeon™, online erschienen am 05.05.2026. Verfasst von Ananya Saravanan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. Hauptthemen laut MEDLINE: Melanoma, Skin Neoplasms, Microsatellite Repeats. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Microsatellites are an adverse prognostic feature in melanoma that upstages node-negative disease to N1c in the AJCC 8th edition staging system. While Breslow thickness and microsatellites are established prognostic markers, their relationship in primary cutaneous melanoma has not been well examined. Materials and Methods We conducted a single-institution retrospective review of an IRB-approved prospective database of patients with primary cutaneous melanoma (January 2016-January 2026), excluding those with metastatic disease at diagnosis. Microsatellites are microscopic foci of melanoma cells discontinuous from the primary tumor and located in the dermis, subcutis, separated from the main tumor by normal tissue with no fibrosis or inflammation. Breslow thickness was measured from the granular layer (or the base of ulceration) to the deepest invasive melanoma cell. Patients were grouped by Breslow-based T-stage, and microsatellite frequency was calculated for each group. Fisher’s exact test evaluated the association between T-stage and microsatellite presence.
Results
Among 1,904 patients, 87 (4.6%) had microsatellites, with one patient having two separate microsatellite-positive tumors. Microsatellite frequency increased progressively with T-stage: 0.1% of T1 tumors (1/924), 2.4% of T2 tumors (14/579), 9.1% of T3 tumors (28/309), and 17.8% of T4 tumors (45/253) (Fisher’s exact p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
- Department of Dermatology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
ORCID-Profile: Ananya Saravanan, P Veronica Pham
Zitieren
APA
Saravanan, A., Parker, E. L., Pham, P. V., Peery, G. B., Googe, P. B., Al-Rohil, R. N., Miedema, J. R., Meyers, M. O., Tyler, D. S., & Ollila, D. W. (2026). Breslow Thickness and Microsatellite Detection in Primary Cutaneous Melanoma: Implications for Oncologic Surgeons and Patients. The American Surgeon™, 92(9), 2257-2262. https://doi.org/10.1177/00031348261448890
Vancouver
Saravanan A, Parker EL, Pham PV, Peery GB, Googe PB, Al-Rohil RN, et al. Breslow Thickness and Microsatellite Detection in Primary Cutaneous Melanoma: Implications for Oncologic Surgeons and Patients. The American Surgeon™. 2026;92(9):2257-2262. doi:10.1177/00031348261448890
BibTeX
@article{Saravanan2026,
author = {Saravanan, Ananya and Parker, Erica L and Pham, P Veronica and Peery, Gray B and Googe, Paul B and Al-Rohil, Rami N and Miedema, Jayson R and Meyers, Michael O and Tyler, Douglas S and Ollila, David W},
title = {Breslow Thickness and Microsatellite Detection in Primary Cutaneous Melanoma: Implications for Oncologic Surgeons and Patients},
journal = {The American Surgeon™},
year = {2026},
volume = {92},
number = {9},
pages = {2257--2262},
doi = {10.1177/00031348261448890}
}
EUVIMED